These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. IN VITRO AND IN VIVO MODELS OF AMYOTROPHIC LATERAL SCLEROSIS: AN UPDATED OVERVIEW. Gois AM; Mendonça DMF; Freire MAM; Santos JR Brain Res Bull; 2020 Jun; 159():32-43. PubMed ID: 32247802 [TBL] [Abstract][Full Text] [Related]
11. The genetics and neuropathology of amyotrophic lateral sclerosis. Al-Chalabi A; Jones A; Troakes C; King A; Al-Sarraj S; van den Berg LH Acta Neuropathol; 2012 Sep; 124(3):339-52. PubMed ID: 22903397 [TBL] [Abstract][Full Text] [Related]
12. A novel mouse model with impaired dynein/dynactin function develops amyotrophic lateral sclerosis (ALS)-like features in motor neurons and improves lifespan in SOD1-ALS mice. Teuling E; van Dis V; Wulf PS; Haasdijk ED; Akhmanova A; Hoogenraad CC; Jaarsma D Hum Mol Genet; 2008 Sep; 17(18):2849-62. PubMed ID: 18579581 [TBL] [Abstract][Full Text] [Related]
13. Interaction between familial amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants and the dynein complex. Zhang F; Ström AL; Fukada K; Lee S; Hayward LJ; Zhu H J Biol Chem; 2007 Jun; 282(22):16691-9. PubMed ID: 17403682 [TBL] [Abstract][Full Text] [Related]
14. Nonoxidative protein glycation is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Shibata N; Nagai R; Miyata S; Jono T; Horiuchi S; Hirano A; Kato S; Sasaki S; Asayama K; Kobayashi M Acta Neuropathol; 2000 Sep; 100(3):275-84. PubMed ID: 10965797 [TBL] [Abstract][Full Text] [Related]
15. Early onset of severe familial amyotrophic lateral sclerosis with a SOD-1 mutation: potential impact of CNTF as a candidate modifier gene. Giess R; Holtmann B; Braga M; Grimm T; Müller-Myhsok B; Toyka KV; Sendtner M Am J Hum Genet; 2002 May; 70(5):1277-86. PubMed ID: 11951178 [TBL] [Abstract][Full Text] [Related]
16. Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis. Pokrishevsky E; Grad LI; Yousefi M; Wang J; Mackenzie IR; Cashman NR PLoS One; 2012; 7(4):e35050. PubMed ID: 22493728 [TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling toward understanding of ALS pathogenesis. Tanaka F; Niwa J; Ishigaki S; Katsuno M; Waza M; Yamamoto M; Doyu M; Sobue G Ann N Y Acad Sci; 2006 Nov; 1086():1-10. PubMed ID: 17185501 [TBL] [Abstract][Full Text] [Related]
19. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations. Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983 [TBL] [Abstract][Full Text] [Related]
20. HtrA2/Omi-immunoreactive intraneuronal inclusions in the anterior horn of patients with sporadic and Cu/Zn superoxide dismutase (SOD1) mutant amyotrophic lateral sclerosis. Kawamoto Y; Ito H; Kobayashi Y; Suzuki Y; Akiguchi I; Fujimura H; Sakoda S; Kusaka H; Hirano A; Takahashi R Neuropathol Appl Neurobiol; 2010 Jun; 36(4):331-44. PubMed ID: 20202124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]